Cantor’s Virtual Brain Week 2, hosted by Cantor’s Biotech Equity Research Team, featured fireside chats and virtual NDR meetings with Neuro-Innovator companies. The conference featured summaries of “lessons learned” following Fall/Winter ’23 clinical conferences, including ADPD, AAN, APA, and Endo. The discussions also previewed impactful news flow/data that may set the stage for alpha generation by investing in practice-change neuro/psych therapies in 2024.